Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
The Big A Trial: Aspirin in Resected NSCLC
NCT01058902Phase 3Withdrawn
- Sponsor
- Liverpool Heart and Chest Hospital
- Start
- Aug 2010
- Primary completion
- Aug 2015
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 3 trial of aspirin in non-small cell lung cancer (NSCLC), sponsored by Liverpool Heart and Chest Hospital. Planned start Aug 2010; status: withdrawn.
02
Drugs
aspirin
03
Conditions
non-small cell lung cancer (NSCLC)
Beyond the preview
Go deeper on NCT01058902.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01058902.